University of Nigeria, Nsukka

About: University of Nigeria, Nsukka is a education organization based out in Nsukka, Nigeria. It is known for research contribution in the topics: Population & Health care. The organization has 10211 authors who have published 13685 publications receiving 138922 citations.

An extraordinary outburst in the massive protostellar system NGC 6334I-MM1 : quadrupling of the millimeter continuum

Abstract: Based on sub-arcsecond Atacama Large Millimeter/submillimeter Array (ALMA) and Submillimeter Array (SMA) 1.3 mm continuum images of the massive protocluster NGC 6334I obtained in 2015 and 2008, we find that the dust emission from MM1 has increased by a factor of 4.0±0.3 during the intervening years, and undergone a significant change in morphology. The continuum emission from the other cluster members (MM2, MM4 and the UCHII region MM3=NGC 6334F) has remained constant. Long term single-dish maser monitoring at HartRAO finds that multiple maser species toward NGC 6334I flared beginning in early 2015, a few months before our ALMA observation, and some persist in that state. New ALMA images obtained in 2016 July-August at 1.1 and 0.87 mm confirm the changes with respect to SMA 0.87 mm images from 2008, and indicate that the (sub)millimeter flaring has continued for at least a year. The excess continuum emission, centered on the hypercompact HII region MM1B, is extended and elongated (1.6 × 1.0 ≈ 2100 × 1300 au) with multiple peaks, suggestive of general heating of the surrounding subcomponents of MM1, some of which may trace clumps in a fragmented disk rather than separate protostars. In either case, these remarkable increases in maser and dust emission provide direct observational evidence of a sudden accretion event in the growth of a massive protostar yielding a sustained luminosity surge by a factor of 70± 20, analogous to the largest events in simulations by Meyer et al. (2017). This target provides an excellent opportunity to assess the impact of such a rare event on a protocluster over many years.

Global Retinoblastoma Presentation and Analysis by National Income Level

Abstract: Importance: Early diagnosis of retinoblastoma, the most common intraocular cancer, can save both a child's life and vision. However, anecdotal evidence suggests that many children across the world are diagnosed late. To our knowledge, the clinical presentation of retinoblastoma has never been assessed on a global scale. Objectives: To report the retinoblastoma stage at diagnosis in patients across the world during a single year, to investigate associations between clinical variables and national income level, and to investigate risk factors for advanced disease at diagnosis. Design, Setting, and Participants: A total of 278 retinoblastoma treatment centers were recruited from June 2017 through December 2018 to participate in a cross-sectional analysis of treatment-naive patients with retinoblastoma who were diagnosed in 2017. Main Outcomes and Measures: Age at presentation, proportion of familial history of retinoblastoma, and tumor stage and metastasis. Results: The cohort included 4351 new patients from 153 countries; the median age at diagnosis was 30.5 (interquartile range, 18.3-45.9) months, and 1976 patients (45.4%) were female. Most patients (n = 3685 [84.7%]) were from low- and middle-income countries (LMICs). Globally, the most common indication for referral was leukocoria (n = 2638 [62.8%]), followed by strabismus (n = 429 [10.2%]) and proptosis (n = 309 [7.4%]). Patients from high-income countries (HICs) were diagnosed at a median age of 14.1 months, with 656 of 666 (98.5%) patients having intraocular retinoblastoma and 2 (0.3%) having metastasis. Patients from low-income countries were diagnosed at a median age of 30.5 months, with 256 of 521 (49.1%) having extraocular retinoblastoma and 94 of 498 (18.9%) having metastasis. Lower national income level was associated with older presentation age, higher proportion of locally advanced disease and distant metastasis, and smaller proportion of familial history of retinoblastoma. Advanced disease at diagnosis was more common in LMICs even after adjusting for age (odds ratio for low-income countries vs upper-middle-income countries and HICs, 17.92 [95% CI, 12.94-24.80], and for lower-middle-income countries vs upper-middle-income countries and HICs, 5.74 [95% CI, 4.30-7.68]). Conclusions and Relevance: This study is estimated to have included more than half of all new retinoblastoma cases worldwide in 2017. Children from LMICs, where the main global retinoblastoma burden lies, presented at an older age with more advanced disease and demonstrated a smaller proportion of familial history of retinoblastoma, likely because many do not reach a childbearing age. Given that retinoblastoma is curable, these data are concerning and mandate intervention at national and international levels. Further studies are needed to investigate factors, other than age at presentation, that may be associated with advanced disease in LMICs.